Gilead Sciences Inc (GILD)
64.92
-0.54
(-0.82%)
USD |
NASDAQ |
May 08, 16:00
65.30
+0.38
(+0.59%)
After-Hours: 20:00
Gilead Sciences Total Return Level: 88.27 for May 8, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 08, 2024 | 88.27 |
May 07, 2024 | 89.01 |
May 06, 2024 | 89.12 |
May 03, 2024 | 88.08 |
May 02, 2024 | 88.83 |
May 01, 2024 | 89.08 |
April 30, 2024 | 88.66 |
April 29, 2024 | 89.66 |
April 26, 2024 | 88.95 |
April 25, 2024 | 88.75 |
April 24, 2024 | 91.21 |
April 23, 2024 | 91.14 |
April 22, 2024 | 91.04 |
April 19, 2024 | 90.78 |
April 18, 2024 | 89.96 |
April 17, 2024 | 91.01 |
April 16, 2024 | 91.52 |
April 15, 2024 | 92.12 |
April 12, 2024 | 92.56 |
April 11, 2024 | 93.35 |
April 10, 2024 | 92.63 |
April 09, 2024 | 95.10 |
April 08, 2024 | 94.39 |
April 05, 2024 | 94.61 |
April 04, 2024 | 94.57 |
Date | Value |
---|---|
April 03, 2024 | 96.39 |
April 02, 2024 | 98.02 |
April 01, 2024 | 99.10 |
March 28, 2024 | 99.60 |
March 27, 2024 | 99.28 |
March 26, 2024 | 98.46 |
March 25, 2024 | 98.69 |
March 22, 2024 | 98.73 |
March 21, 2024 | 99.38 |
March 20, 2024 | 100.59 |
March 19, 2024 | 99.82 |
March 18, 2024 | 99.62 |
March 15, 2024 | 100.20 |
March 14, 2024 | 100.91 |
March 13, 2024 | 102.20 |
March 12, 2024 | 101.04 |
March 11, 2024 | 101.36 |
March 08, 2024 | 101.10 |
March 07, 2024 | 99.13 |
March 06, 2024 | 97.74 |
March 05, 2024 | 98.23 |
March 04, 2024 | 97.23 |
March 01, 2024 | 97.31 |
February 29, 2024 | 97.03 |
February 28, 2024 | 97.84 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
67.35
Minimum
Dec 30 2020
117.47
Maximum
Jan 19 2024
86.77
Average
83.05
Median
Aug 02 2021
Total Return Level Benchmarks
Amgen Inc | 427.23 |
CymaBay Therapeutics Inc (DELISTED) | -- |
Bristol-Myers Squibb Co | 174.74 |
Eli Lilly and Co | 2230.79 |
Xilio Therapeutics Inc | 1.21 |